Please use this identifier to cite or link to this item:
https://olympias.lib.uoi.gr/jspui/handle/123456789/21883| Title: | Erlotinib and pancreatic adenocarcinoma: uncertainty and hope |
| Institution and School/Department of submitter: | Πανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικής |
| Keywords: | Adenocarcinoma/*drug therapy,Antineoplastic Combined Chemotherapy Protocols/*therapeutic use,Female,Humans,Male,Pancreatic Neoplasms/*drug therapy |
| URI: | https://olympias.lib.uoi.gr/jspui/handle/123456789/21883 |
| ISSN: | 1534-4681 |
| Link: | http://www.ncbi.nlm.nih.gov/pubmed/21630121 http://www.springerlink.com/content/u7k5583n383r3t03/fulltext.pdf |
| Appears in Collections: | Άρθρα σε επιστημονικά περιοδικά ( Ανοικτά) - ΙΑΤ |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| Zoras-2011-Erlotinib and pancre.pdf | 126.38 kB | Adobe PDF | View/Open Request a copy |
This item is licensed under a Creative Commons License
